|
Indication |
For active immunization of infants 6 weeks to 15
months of age born of HBsAg-negative mothers who
need protection against both Hib and Hepatitis B |
|
Proprietary Name |
Comvax (combination of Pedvax HIB and Recombivax
HIB vaccines) |
|
Manufacturer |
Merck |
|
Viability |
Inactivated |
|
Microorganism |
H. influenzae type b, Virus family
Hepadnaviridae |
|
Dose |
0.5 mL |
|
Route |
Intramuscular |
|
Dose form |
Suspension |
|
Appearance |
Aluminum Hydroxide, ≤0.625 mg |
|
Concentration (per 0.5 mL) |
Hib polysaccharide, 7.5 mcg
Hepatitis B surface antigen, 5 mcg |
|
Preservatives |
None |
|
Adjuvant |
Neisseria meningitides OMP, 125mcg
Aluminum hydroxide, 225mcg |
|
Excipients |
Sodium borate decahydrate, 35mcg
Yeast protein, ≤1%
Formaldehyde,
≤0.0004% |
|
Allergens |
None |
|
Media |
Hib: Complex fermentation media; Hepatitis B: S.
cerevisiae |
|
Packaging |
Box of 10 single-dose vials |
|
Routine storage |
2 to 8°
C (36-46°
F)
Do Not Freeze |
|
updated July 2005 |